RT @infecciosasryc: Artículo relevante en #CoVID19: https://t.co/R3t5DqStiC No se observa beneficio asociado al uso de lopinavir/r (14 días…
RT @ABsteward: RCT 200 pts with severe #COVID19 published @NEJM In hospitalized adult patients with severe Covid-19, no benefit was observe…
RT @IlindelatorreMD: #Covid19 En pacientes adultos hospitalizados con Covid-19 grave, no se observó ningún beneficio con el tratamiento lo…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
The lopinavir-ritonavir trial out showing no benefit in patients hospitalised with COVID-19. However, remarkable and unprecedented to have trial results so early in an outbreak. https://t.co/PjIzOxop6n
LOL. Just got 5 different pings from 5 different individuals for this study. #COVID-19 #myteamrocks @DASON_duke @Duke_ASET https://t.co/R1eT6HncgA
RT @ABsteward: Nearly 14% of lopinavir–ritonavir recipients were unable to complete the full 14-day course of administration. Mainly GI eff…
Los pacientes asignados a lopinavir-ritonavir no tuvieron un tiempo de mejoría clínica diferente al de los pacientes asignados a la atención estándar (mediana, 16 días frente a 16 días)https://t.co/958gh8beoR
RT @NephroGuy: Lopinavir/ritonavir is no better than standar medical care. #COVID19 #FlattenTheCurve @thecurbsiders @CPSolvers @ETSshow @…
@JayJoJoJr Eher kalter. https://t.co/s8CWCVZX1G
RT @Laurie_Garrett: Sadly, the cocktail of anti-#HIV drugs that many hoped would treat #COVID19 has failed. "In hospitalized adult patients…
RT @VladoPerkovic: First pretty robust trial of an intervention in COVID-19 @NEJM . Little if any benefit from lopinavir–ritonavir in moder…
RT @peripatetical: Lopinavir/r vs placebo for hopitalized adults with #COVID19. Most not on NIV/MV at baseline but mortality still 19% vs 2…
RT @mugecevik: 28/ 1st clinical trial of Lopinavir–Ritonavir in #COVID19: Among 199 seriously ill lab-confirmed cases, no significant benef…
RT @Laurie_Garrett: Sadly, the cocktail of anti-#HIV drugs that many hoped would treat #COVID19 has failed. "In hospitalized adult patients…
RT @jimcramer: Darn thing is hard to beat https://t.co/mTT6W3KhW3
@imhawk @drharshvardhan @NavbharatTimes well here's someone confirming that it doesn't work https://t.co/s8CWCVZX1G
RT @CarlosdelRio7: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | No benefit observed in #COVID19 in these pa…
RT @SICUPharmD: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 did not show any benefit I. This small study @S…
NEJM 18 March: "In hospitalized adult patients with severe Covid-19, no benefit was observed with lopi- navir–ritonavir treatment beyond standard care" Descargar gratis: https://t.co/dCKnGkdPAN #ups #COVID19
RT @DrPascalMeier: That was fast! First randomised trial for #Covid19 therapy: Lopinavir–ritonavir has no or minimal effect @NEJM https:…
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @DrPascalMeier: That was fast! First randomised trial for #Covid19 therapy: Lopinavir–ritonavir has no or minimal effect @NEJM https:…
RT @ProfMakris: Results of the 1st Randomised trial in COVID-19. Unfortunately the addition of Lopinovir-Ritonavir did not lead to better o…
RT @ProfMakris: Results of the 1st Randomised trial in COVID-19. Unfortunately the addition of Lopinovir-Ritonavir did not lead to better o…
RT @DrPascalMeier: That was fast! First randomised trial for #Covid19 therapy: Lopinavir–ritonavir has no or minimal effect @NEJM https:…
RT @ASPphysician: First major RCT in severe #COVID19 Rx. First: wow! This disease is a few months old, and we have an RCT with ~200 patien…
RT @Laurie_Garrett: Sadly, the cocktail of anti-#HIV drugs that many hoped would treat #COVID19 has failed. "In hospitalized adult patients…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
#Covid19 En pacientes adultos hospitalizados con Covid-19 grave, no se observó ningún beneficio con el tratamiento lopinavir / ritonavir (Kaletra). https://t.co/k5xRgISg9v
RT @DrPascalMeier: That was fast! First randomised trial for #Covid19 therapy: Lopinavir–ritonavir has no or minimal effect @NEJM https:…
RT @KamiMasahiro: もうRCTの結果が出ています。 https://t.co/dbE8VREUo7
@medsdeltaonline trial failed, see here https://t.co/s8CWCVZX1G
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @DrPascalMeier: That was fast! First randomised trial for #Covid19 therapy: Lopinavir–ritonavir has no or minimal effect @NEJM https:…
RT @SIDPharm: New in NEJM! RCT (open label) of lopinavir/ritonavir in adult patients hospitalized for COVID19. Results: no benefit over ser…
@StrictlyAsking sadly, here's another red X https://t.co/s8CWCVZX1G
RT @SIDPharm: New in NEJM! RCT (open label) of lopinavir/ritonavir in adult patients hospitalized for COVID19. Results: no benefit over ser…
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @DrPascalMeier: That was fast! First randomised trial for #Covid19 therapy: Lopinavir–ritonavir has no or minimal effect @NEJM https:…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @CarlosdelRio7: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | No benefit observed in #COVID19 in these pa…
That was fast! First randomised trial for #Covid19 therapy: Lopinavir–ritonavir has no or minimal effect @NEJM https://t.co/1Jnh0H3ovM https://t.co/w4bS2ry5sh
RT @Laurie_Garrett: Sadly, the cocktail of anti-#HIV drugs that many hoped would treat #COVID19 has failed. "In hospitalized adult patients…
Results of the 1st Randomised trial in COVID-19. Unfortunately the addition of Lopinovir-Ritonavir did not lead to better outcome than standard care. Amazingly they designed, carried out and reported an RCT within 3 months of COVID19 first being recognised
@RobertoBurioni Dottore @RobertoBurioni , cosa ne pensa di questa pubblicazione? Sembra che questi farmaci non funzionano :-( https://t.co/6QPbRLQCA4
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM https://t.co/w74t71bjsx
Lopinavir-Ritonavir: NO difference in time to improvement or 28d mortality from standard care https://t.co/A1mIGCRpHK #COVID19 #Covid_19
RT @docramiro: El uso de Lopinavir/ritonavir para el nuevo #coronavirus #COVID19 no resultó en menor mortalidad ni cambios en carga viral c…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @DrToddLee: This is a good example of why you do RCTs and don't just randomly give experimental drugs because theory says they work. Ne…
RT @raj_mehta: NEJM, what are you doing? Now is not the time to engage in dichotomania of statistical significance. The conclusions (no…
https://t.co/B11USwrQGS First trial failed to show benefit in treatment of severe COVID19 patients with Lopinavir-Ritonavir!
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
カトレラ(ロピナビル・リトナビル HIVの薬)の重症例(といっても酸素飽和度94%以下)の速報 主要評価項目である臨床的な改善までの期間は差がありませんでした。 28日目での死亡率は非投与群の25%に対し19.2%でした。期待したほどではなかった、カトレラw NEJM https://t.co/Tkbohus1Yy https://t.co/XKzlyPlAhe
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
@KaplanBen_Fr tests fini https://t.co/s8CWCVZX1G
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @ABsteward: RCT 200 pts with severe #COVID19 published @NEJM In hospitalized adult patients with severe Covid-19, no benefit was observe…
RT @JuanCGabaldon: Otra combinación, que incluso llegó a salir en protocolos de los ministerios de salud de varios países latinoamericanos,…
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @jimcramer: Darn thing is hard to beat https://t.co/mTT6W3KhW3
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @ABsteward: Nearly 14% of lopinavir–ritonavir recipients were unable to complete the full 14-day course of administration. Mainly GI eff…
@KaplanBen_Fr le deuxieme ne marche pas https://t.co/s8CWCVZX1G
RT @jimcramer: Darn thing is hard to beat https://t.co/mTT6W3KhW3
RT @Laurie_Garrett: Sadly, the cocktail of anti-#HIV drugs that many hoped would treat #COVID19 has failed. "In hospitalized adult patients…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
NEJM, what are you doing? Now is not the time to engage in dichotomania of statistical significance. The conclusions (no significant difference) is not compatible with the data (HR for improvement 1.24; 0.90 to 1.72) Cc @f2harrell @ADAlthousePhD https
RT @julienpotet: Randomized controlled open-label trial of #lopinavir/ritonavir (LPV/r) for #COVID19 finds no benefit compared to control g…
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @ABsteward: RCT 200 pts with severe #COVID19 published @NEJM In hospitalized adult patients with severe Covid-19, no benefit was observe…
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @infecciosasryc: Artículo relevante en #CoVID19: https://t.co/R3t5DqStiC No se observa beneficio asociado al uso de lopinavir/r (14 días…
RT @aliciad3: Not that there were high hopes... https://t.co/DLrSoLCedP
RT @SIDPharm: New in NEJM! RCT (open label) of lopinavir/ritonavir in adult patients hospitalized for COVID19. Results: no benefit over ser…
RT @jimcramer: Darn thing is hard to beat https://t.co/mTT6W3KhW3
RT @Laurie_Garrett: Sadly, the cocktail of anti-#HIV drugs that many hoped would treat #COVID19 has failed. "In hospitalized adult patients…
No benefit observed with #lopinavir #ritonavir compare to SOC for hospitalized adult with severe #COVID19. Congratulations to our chinese colleagues: Incredible to publish a #RCT in such short notice! #FlattenTheCurve @NEJM @mcgillu @univ_lille https://t.
RT @vmcorman: "In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond stand…
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
RT @donni__69: Un ensayo chino con lopinavir-ritonavir no consigue demostrar claro beneficio en pacientes con #COVID19. La mortalidad y est…
RT @ArgenidaRomero: Atención
RT @nickmmark: Randomized Controlled Study of Standard care ± Lopinavir–Ritonavir in hospitalized patients with COVID19 found no significan…
RT @pmarsupia: 🔴Nuevo artículo científico sobre el coronavirus: Malas noticias. Parece que el tratamiento con lopinavir–ritonavir no mejor…
@ParuchMD doesn't even work don't bother https://t.co/s8CWCVZX1G
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @DrToddLee: This is a good example of why you do RCTs and don't just randomly give experimental drugs because theory says they work. Ne…